Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Antibodies > Primary antibodies

Anti-Human CTNNB1 Recombinant Nanobody (SAA1410) (HW518033)

Anti-Human CTNNB1 Recombinant Nanobody (SAA1410)
Anti-Human CTNNB1 Recombinant Nanobody (SAA1410)
Price(USD):
Spec:
  • 20ug
  • 50ug
  • 100ug
  • 1mg
Number:
Get quote
  • Overview

  • Images

  • References

  • Datasheet

  • SDS

Overview
Catalog No.HW518033
Description
Anti-Human CTNNB1 Nanobody (SAA1410) [SAA1410] (HW518033) is a alpaca monoclonal antibody detecting Human CTNNB1 in ELISA. Suitable for Human.
Species reactivityHuman
ApplicationsELISA
Host speciesAlpaca
IsotypeVHH-His
Clone IDSAA1410
Clonality Monoclonal
Target BC2 peptide-tag, BC2e-tag, PDRKAAVSHWQQ
Endotoxin level Please contact with the lab for this information.
Purity >95% as determined by SDS-PAGE.
Purification Purified by Nickel column.
Accession P35222
Form Liquid
Storage buffer 0.01M PBS pH 7.4

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Product Usage Information
Application Dilution
ELISA 1:2000-1:20000
Stability and Storage Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Background

Catenin beta-1 (CTNNB1) is a ~85 kDa protein. Key downstream component of the canonical Wnt signaling pathway. In the absence of Wnt, forms a complex with AXIN1, AXIN2, APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its subsequent degradation by the proteasome. In the presence of Wnt ligand, CTNNB1 is not ubiquitinated and accumulates in the nucleus, where it acts as a coactivator for transcription factors of the TCF/LEF family, leading to activate Wnt responsive genes. Also acts as a coactivator for other transcription factors, such as NR5A2. Promotes epithelial to mesenchymal transition/mesenchymal to epithelial transition (EMT/MET) via driving transcription of CTNNB1/TCF-target genes.

1. Lillehoj, EP. et al. (2007) Biochimica et biophysica acta 1773, 1028-38. PMID: 17524503
2. Weiske, J. et al. (2007) Proceedings of the National Academy of Sciences of the United States of America 104, 20344-9. PMID: 18077326
3. Bahmanyar, S. et al. (2008) Genes & development 22, 91-105. PMID: 18086858
4. Li, H. et al. (2009) The Journal of biological chemistry 284, 2012-22. PMID: 18957423
5. Fiset, A. et al. (2011) Cellular signalling 23, 911-9. PMID: 21262353
6. Satow, R. et al. (2012) Gastroenterology 142, 572-81. PMID: 22155184
7. Genovese, G. et al. (2012) Cell cycle (Georgetown, Tex.) 11, 2206-15. PMID: 22647378
8. Yu, Y. et al. (2012) EMBO reports 13, 750-8. PMID: 22699938
10. Park, J. et al. (2018) Stem cell reports 11, 115-127. PMID: 29910125
Note For research use only.
Images
  • Anti-Human CTNNB1 Recombinant Nanobody (SAA1410)

    SDS-PAGE

    SDS-PAGE for Anti-Human CTNNB1 Nanobody (SAA1410)

References
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommendation

Contact us for custom quotes, bulk requests and any other issues.

Mail: [email protected]

Distributor list